AMARIN CORP PLC\UK Depreciation
AMARIN CORP PLC\UK (AMRN) reported Depreciation of $100.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2025-03-12
- AMARIN CORP PLC\UK depreciation for the quarter ending 2016-12-31 was -$14.00K, a 118.67% decline year-over-year.
- AMARIN CORP PLC\UK depreciation for the quarter ending 2016-09-30 was $35.00K, a 12.50% decline year-over-year.
- AMARIN CORP PLC\UK depreciation for the quarter ending 2015-12-31 was $75.00K.
- AMARIN CORP PLC\UK depreciation for the quarter ending 2015-09-30 was $40.00K.
- AMARIN CORP PLC\UK depreciation for fiscal 2024 was $100.00K, a 50.00% decline from fiscal 2023.
- AMARIN CORP PLC\UK depreciation for fiscal 2023 was $200.00K, a 66.67% decline from fiscal 2022.
- AMARIN CORP PLC\UK depreciation for fiscal 2022 was $600.00K, a 0.00% change from fiscal 2021.
- AMARIN CORP PLC\UK depreciation for fiscal 2021 was $600.00K, a 0.00% change from fiscal 2020.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2024-12-31 | $100.00K 10-K · filed 2025-03-12 | |||
| 2023-12-31 | $200.00K 10-K · filed 2025-03-12 | |||
| 2022-12-31 | $600.00K 10-K · filed 2025-03-12 | |||
| 2021-12-31 | $600.00K 10-K · filed 2024-02-29 | |||
| 2020-12-31 | $600.00K 10-K · filed 2023-03-01 | |||
| 2019-12-31 | $200.00K 10-K · filed 2022-03-01 | |||
| 2017-12-31 | $100.00K 10-K · filed 2020-02-25 | |||
| 2016-12-31 | -$14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $21.00K derived: sum of 2 quarters · filed 2019-02-27 | $100.00K 10-K · filed 2019-02-27 | |
| 2016-09-30 | $35.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $114.00K 10-Q · filed 2016-11-03 | ||
| 2016-06-30 | $79.00K 10-Q · filed 2016-08-04 | |||
| 2015-12-31 | $75.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $115.00K derived: sum of 2 quarters · filed 2018-02-27 | $200.00K 10-K · filed 2018-02-27 | |
| 2015-09-30 | $40.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $125.00K 10-Q · filed 2016-11-03 | ||
| 2015-06-30 | $85.00K 10-Q · filed 2016-08-04 | |||
| 2014-12-31 | $200.00K 10-K · filed 2017-03-01 | |||
| 2013-12-31 | $200.00K 10-K · filed 2016-02-25 | |||
| 2012-12-31 | $200.00K 10-K · filed 2015-03-03 | |||
| 2011-12-31 | $100.00K 10-K · filed 2014-02-27 | |||
| 2010-12-31 | $100.00K 10-K · filed 2013-02-28 | |||
| 2009-12-31 | $600.00K 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |